| Literature DB >> 28493438 |
Tojo Nakayama1,2,3, Jiang Wu4, Patricia Galvin-Parton5, Jody Weiss5, Mary R Andriola5, R Sean Hill1,2,6, Dylan J Vaughan1,2, Malak El-Quessny1,2, Brenda J Barry1,2,6, Jennifer N Partlow1,2,6, A James Barkovich7, Jiqiang Ling4,8, Ganeshwaran H Mochida1,2,3,9.
Abstract
Aminoacyl-transfer RNA (tRNA) synthetases ligate amino acids to specific tRNAs and are essential for protein synthesis. Although alanyl-tRNA synthetase (AARS) is a synthetase implicated in a wide range of neurological disorders from Charcot-Marie-Tooth disease to infantile epileptic encephalopathy, there have been limited data on their pathogenesis. Here, we report loss-of-function mutations in AARS in two siblings with progressive microcephaly with hypomyelination, intractable epilepsy, and spasticity. Whole-exome sequencing identified that the affected individuals were compound heterozygous for mutations in AARS gene, c.2067dupC (p.Tyr690Leufs*3) and c.2738G>A (p.Gly913Asp). A lymphoblastoid cell line developed from one of the affected individuals showed a strong reduction in AARS abundance. The mutations decrease aminoacylation efficiency by 70%-90%. The p.Tyr690Leufs*3 mutation also abolished editing activity required for hydrolyzing misacylated tRNAs, thereby increasing errors during aminoacylation. Our study has extended potential mechanisms underlying AARS-related disorders to include destabilization of the protein, aminoacylation dysfunction, and defective editing activity.Entities:
Keywords: AARS; aminoacylation defect; hypomyelination; microcephaly; transfer RNA
Mesh:
Substances:
Year: 2017 PMID: 28493438 PMCID: PMC5599341 DOI: 10.1002/humu.23250
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878